{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T18:52:54Z","timestamp":1771527174922,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS) KAKENHI","doi-asserted-by":"publisher","award":["24791676"],"award-info":[{"award-number":["24791676"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.clgc.2016.04.002","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T06:44:12Z","timestamp":1460270652000},"page":"e493-e499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection"],"prefix":"10.1016","volume":"14","author":[{"given":"Hideo","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Yoshiike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiari","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Usuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Katsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichirou","family":"Aida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Hoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ochiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Chikaraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2016.04.002_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","article-title":"The present and future burden of urinary bladder cancer in the world","volume":"27","author":"Ploeg","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2016.04.002_bib2","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2016.04.002_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","article-title":"Bladder cancer","volume":"374","author":"Kaufman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2016.04.002_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.2015.1024656","article-title":"Intravesical therapy for bladder cancer","volume":"16","author":"Patel","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clgc.2016.04.002_bib5","first-page":"155","article-title":"NBI\u2013plasma vaporization hybrid approach in bladder cancer endoscopic management","volume":"7","author":"St\u0103nescu","year":"2014","journal-title":"J\u00a0Med Life"},{"key":"10.1016\/j.clgc.2016.04.002_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1756287213510590","article-title":"Blue-light cystoscopy in the evaluation of non-muscle-invasive bladder cancer","volume":"6","author":"Oude Elferink","year":"2014","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.clgc.2016.04.002_bib7","first-page":"2464","volume":"vol. 3","author":"Meredith","year":"2007"},{"key":"10.1016\/j.clgc.2016.04.002_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4111\/kju.2014.55.10.650","article-title":"Usefulness of urine cytology as a routine work-up in the detection of recurrence in patients with prior non-muscle-invasive bladder cancer: practicality and cost-effectiveness","volume":"55","author":"Ok","year":"2014","journal-title":"Korean J Urol"},{"key":"10.1016\/j.clgc.2016.04.002_bib9","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/cncr.25903","article-title":"Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis","volume":"117","author":"Shariat","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2016.04.002_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00345-007-0230-3","article-title":"The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies","volume":"26","author":"Raitanen","year":"2008","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2016.04.002_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1309\/ADJL7E810U1H42BJ","article-title":"Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings","volume":"127","author":"Yoder","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clgc.2016.04.002_bib12","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/jclinpath-2012-200812","article-title":"Non-invasive urine based tests for the detection of bladder cancer","volume":"65","author":"Wadhwa","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clgc.2016.04.002_bib13","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.5489\/cuaj.1196","article-title":"The management of BCG failure in non-muscle-invasive bladder cancer: an update","volume":"3","author":"Zlotta","year":"2009","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.clgc.2016.04.002_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.clgc.2016.04.002_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.canlet.2009.04.031","article-title":"MicroRNAs: novel regulators in the hallmarks of human cancer","volume":"285","author":"Ruan","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clgc.2016.04.002_bib16","doi-asserted-by":"crossref","first-page":"e109734","DOI":"10.1371\/journal.pone.0109734","article-title":"MicroRNA-137 upregulation increases bladder cancer cell proliferation and invasion by targeting PAQR3","volume":"9","author":"Xiu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2016.04.002_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12032-014-0197-z","article-title":"Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer","volume":"31","author":"Zhou","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.clgc.2016.04.002_bib18","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3892\/ol.2015.2959","article-title":"Biomarkers for gastric cancer: progression in early diagnosis and prognosis","volume":"9","author":"Jin","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clgc.2016.04.002_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/bjc.2015.206","article-title":"miR-30e* is an independent subtype-specific prognostic marker in breast cancer","volume":"113","author":"D'Aiuto","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2016.04.002_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/bjc.2015.111","article-title":"Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients","volume":"113","author":"Summerer","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2016.04.002_bib21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1349-7006.2010.01816.x","article-title":"MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology","volume":"102","author":"Yamada","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clgc.2016.04.002_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class\u00a0of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.clgc.2016.04.002_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2217\/bmm.13.44","article-title":"Stability of miRNA in human urine supports its biomarker potential","volume":"7","author":"Mall","year":"2013","journal-title":"Biomark Med"},{"key":"10.1016\/j.clgc.2016.04.002_bib24","doi-asserted-by":"crossref","first-page":"e1082","DOI":"10.7717\/peerj.1082","article-title":"Urinary microRNA can be concentrated, dried on membranes and stored at room temperature in vacuum bags","volume":"3","author":"Zhang","year":"2015","journal-title":"PeerJ"},{"key":"10.1016\/j.clgc.2016.04.002_bib25","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clgc.2016.04.002_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40463-015-0083-5","article-title":"Serum microRNA profiling to distinguish papillary thyroid cancer from benign thyroid masses","volume":"44","author":"Graham","year":"2015","journal-title":"J\u00a0Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clgc.2016.04.002_bib27","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/pros.23068","article-title":"Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1","volume":"75","author":"Xu","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.clgc.2016.04.002_bib28","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/pros.22878","article-title":"miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1","volume":"74","author":"Sun","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.clgc.2016.04.002_bib29","first-page":"197","article-title":"The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis","volume":"45","author":"Li","year":"2014","journal-title":"Int J\u00a0Oncol"},{"key":"10.1016\/j.clgc.2016.04.002_bib30","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1158\/0008-5472.CAN-12-0688","article-title":"Genetic variants in miRNAs predict bladder cancer risk and recurrence","volume":"72","author":"Wang","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.clgc.2016.04.002_bib31","doi-asserted-by":"crossref","first-page":"e79584","DOI":"10.1371\/journal.pone.0079584","article-title":"Association between microRNA polymorphisms and cancer risk based on the findings of 66 case\u2013control studies","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2016.04.002_bib32","doi-asserted-by":"crossref","first-page":"32586","DOI":"10.18632\/oncotarget.5309","article-title":"MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2","volume":"20","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.clgc.2016.04.002_bib33","first-page":"409","article-title":"Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy","volume":"39","author":"Drebber","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.clgc.2016.04.002_bib34","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/carcin\/bgt006","article-title":"Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer","volume":"34","author":"Ke","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clgc.2016.04.002_bib35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4111\/kju.2013.54.11.791","article-title":"Cell-free microRNA-214 from urine as a biomarker for non-muscle-invasive bladder cancer","volume":"54","author":"Kim","year":"2013","journal-title":"Korean J Urol"},{"key":"10.1016\/j.clgc.2016.04.002_bib36","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3899\/jrheum.100308","article-title":"Serum and urinary cell-free miR-146a and miR-155 in patients with systemic lupus erythematosus","volume":"37","author":"Wang","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clgc.2016.04.002_bib37","doi-asserted-by":"crossref","first-page":"e100793","DOI":"10.1371\/journal.pone.0100793","article-title":"Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2016.04.002_bib38","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clgc.2016.04.002_bib39","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/annrheumdis-2014-205409","article-title":"Role of miR-146a in regulation of the acute inflammatory response to monosodium urate crystals","volume":"74","author":"Dalbeth","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316300787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767316300787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:26:16Z","timestamp":1761564376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767316300787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1558767316300787"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2016.04.002","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2016.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}